How does Deplin (L‑methylfolate) compare to over‑the‑counter methylated folate supplements regarding dosage, indications, and clinical use?

Deplin vs. Over-the-Counter Methylated Folate Supplements

Deplin (L-methylfolate) is a prescription medical food containing pharmaceutical-grade L-methylfolate at standardized doses of 7.5 mg or 15 mg, whereas over-the-counter methylated folate supplements are dietary supplements with variable quality, lower doses (typically 400-1000 mcg), and no FDA oversight for purity or bioavailability.

Key Distinctions

Regulatory Status and Quality Control

• Deplin is classified as a prescription medical food, meaning it requires physician oversight and is manufactured under pharmaceutical standards with guaranteed potency and purity
• OTC supplements are dietary supplements regulated less stringently, with potential variability in actual L-methylfolate content, bioavailability, and presence of contaminants

Dosage Differences

The therapeutic doses studied for clinical efficacy differ dramatically:

• Deplin: Available in 7.5 mg and 15 mg doses

  • The 15 mg dose showed significant efficacy in treating SSRI-resistant major depressive disorder 1
  • In real-world use, patients taking Deplin achieved a 58.2% reduction in depression scores with 67.9% response rate and 45.7% remission rate 2

• OTC methylated folate: Typically contains 400-1000 mcg (0.4-1 mg)

  • These doses align with general nutritional supplementation recommendations (330 mcg DFE for adults per ESPEN guidelines) 3
  • A study using only 113 mcg (equimolar to 100 mcg folic acid) showed modest homocysteine reduction but was not studied for psychiatric indications 4

Clinical Indications

Deplin is specifically indicated for:

• Adjunctive treatment of major depressive disorder, particularly SSRI-resistant depression 1
• Patients with elevated inflammatory markers (high-sensitivity CRP) 5
• Patients with BMI ≥30 kg/m² who show enhanced response 5
• Individuals with MTHFR polymorphisms affecting folate metabolism 6, 7

OTC methylated folate is appropriate for:

• General nutritional supplementation in folate deficiency (serum folate <10 nmol/L or RBC folate <340 nmol/L) 3
• Prevention of neural tube defects (though standard folic acid 400 mcg/day is the guideline recommendation) 3
• Maintenance supplementation in chronic conditions requiring ongoing folate support 3

Evidence-Based Dosing for Depression

The clinical trial data is unequivocal about dose-response:

• 7.5 mg dose: Initial trials showed no significant benefit over placebo 1
• 15 mg dose: Demonstrated statistically significant superiority over placebo with number needed to treat of approximately 6 1
• Low-dose supplementation (800 mcg): A recent 2025 study showed 40.33% improvement in depression symptoms when combined with antidepressants, though this was in a small open-label trial 8

The therapeutic dose for psychiatric indications is 15 mg daily, which is 15-37 times higher than typical OTC supplement doses.

Bioavailability and Formulation

L-methylfolate (5-MTHF) is the biologically active form that:

• Bypasses the MTHFR enzyme, making it effective regardless of genetic polymorphisms 3
• Does not require conversion like folic acid
• Crosses the blood-brain barrier more efficiently than folic acid 6

However, pharmaceutical-grade L-methylfolate in Deplin uses specific salt forms (calcium or magnesium L-methylfolate) with documented stability and absorption, whereas OTC products may use different formulations with variable bioavailability.

Safety Considerations

Both forms are generally well-tolerated:

• The upper limit for folic acid is 1 mg/day to avoid masking B12 deficiency 3
• This limit does not apply to L-methylfolate, which does not mask the hematologic signs of B12 deficiency 4
• Deplin at 15 mg/day showed adverse event rates no different from placebo 1
• Always screen for and correct B12 deficiency before or concurrent with folate supplementation 3

Clinical Decision Algorithm

For major depressive disorder with inadequate antidepressant response:

1. Use Deplin 15 mg daily as adjunctive therapy 1
2. Particularly consider if patient has BMI ≥30 or elevated inflammatory markers 5
3. OTC supplements at nutritional doses (400-1000 mcg) are insufficient for this indication

For folate deficiency (documented by lab testing):

1. Use 1-5 mg folic acid daily for 4 months per ESPEN guidelines 3
2. L-methylfolate 1-5 mg daily is an alternative, especially with MTHFR polymorphisms
3. OTC methylated folate at 400-1000 mcg may be used for maintenance after correction

For general health/prevention:

1. Standard folic acid 400 mcg daily is guideline-recommended for neural tube defect prevention 3
2. OTC methylated folate 400-1000 mcg is reasonable for those preferring the active form
3. No evidence supports routine use of high-dose (7.5-15 mg) L-methylfolate without specific indication

Critical Pitfalls to Avoid

• Do not assume OTC methylated folate supplements provide therapeutic psychiatric doses - they typically contain 1/15th to 1/37th of the effective dose
• Always check B12 status before initiating any folate supplementation to avoid neurological complications from masked B12 deficiency 3
• Do not use 7.5 mg Deplin for depression - only the 15 mg dose showed efficacy 1
• Verify actual L-methylfolate content in OTC products, as supplement quality varies significantly
• Monitor folate status at 3 months after supplementation to verify normalization 3